Published in Int Rev Immunol on January 01, 1999
Human embryonic stem cells: preclinical perspectives. J Transl Med (2008) 0.96
Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology (1996) 1.89
Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg (1998) 1.53
MicroRNAs as immune regulators: implications for transplantation. Am J Transplant (2010) 1.16
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation (1995) 1.13
Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol (1997) 1.12
Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med (1995) 1.11
Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology (1995) 0.99
Differential expression of microRNAs during allograft rejection. Am J Transplant (2012) 0.98
Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology (2000) 0.97
Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. Transplant Proc (1995) 0.96
Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation (1993) 0.91
Apoptosis and allograft rejection in the absence of CD8+ T cells. Transplantation (2001) 0.90
Molecular definitions, autoepitopes, and enzymatic activities of the mitochondrial autoantigens of primary biliary cirrhosis. Semin Liver Dis (1989) 0.90
Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway. J Immunol (2001) 0.90
Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation (1995) 0.89
Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis. Liver (2001) 0.88
Intragraft cytokine profile during human liver allograft rejection. Transplantation (1992) 0.88
Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection. Transplantation (1995) 0.88
Characterization of allograft rejection in an experimental model of small intestinal transplantation. J Gastrointest Surg (1999) 0.87
Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma. Am J Transplant (2009) 0.85
Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients. Transplantation (1995) 0.85
Acute liver allograft rejection in the rat. An analysis of the immune response. Transplantation (1995) 0.84
CD30 expression identifies a functional alloreactive human T-lymphocyte subset. Transplantation (1998) 0.81
PI3Kδ inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)+ B cell lymphomas. Am J Transplant (2013) 0.81
Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines. Transplantation (1998) 0.79
IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation (1993) 0.79
Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients. Liver Transpl (2000) 0.78
Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder. Am J Transplant (2013) 0.78
Interleukin-12: a possible cytotoxic T-lymphocyte differentiation factor in allograft recipients. Transplant Proc (1995) 0.78
Cytokines are involved in the rejection of small intestine allografts. Transplant Proc (1997) 0.77
EBV B lymphoma cell lines from patients with post-transplant lymphoproliferative disease are resistant to TRAIL-induced apoptosis. Am J Transplant (2006) 0.77
Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts. Transplantation (1996) 0.77
Acute rejection of small intestine allografts is associated with increased expression of toll-like receptors. Transplant Proc (2010) 0.75
Long-term nonresponsiveness to a liver allograft may be cytokine mediated. Transplant Proc (1995) 0.75
T cell receptor usage by cytotoxic T lymphocytes against autologous human melanoma. Anticancer Res (1997) 0.75
Distinct patterns of Th2 cytokine production during immune activation in pediatric liver allograft recipients. Transplant Proc (1995) 0.75
Intragraft eosinophilia and interleukin-5 mRNA accompany liver allograft rejection. Transplant Proc (1993) 0.75
Characterization of cytokine expression in an animal model of acute liver allograft rejection. Transplant Proc (1995) 0.75
Circulating intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in pediatric liver recipients. Transplant Proc (1995) 0.75
Elevated biliary interleukin 5 as an indicator of liver allograft rejection. Transpl Immunol (1995) 0.75